aTyr Investigative Site

Chicago, Illinois 60612

1 studies enrolling now · 3 studies all time

What they study most

Interstitial Lung Disease, Pulmonary Sarcoidosis

Studies at this site

• Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD) — Recruiting now
• Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis — Completed
• Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis — Completed